[1] BUAS M F,VAUGHAN T L. Epidemiology and risk factors for gastroesophageal junction tumors:understanding the rising incidence of this disease[J]. Semin Radiat Oncol,2013,23(1):3-9.[2] JEMAL A,SIEGEL R,WARD E,et al. Cancer statistics,2008[J]. CA Cancer J Clin,2008,58(2):71-96.[3] FELDMANN R,SCHIERL M,FINK A M,et al. Serum levels of glycoprotein Dickkopf-1 in patients with cutaneous malignant melanoma:a prospective pilot study[J]. Dermatology,2011,222(2):171-175.[4] SHEN Q,FAN J,YANG X R,et al. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma:a large-scale,multicentre study[J]. Lancet Oncol,2012,13(8):817-826.[5] PENG Y H,XU Y W,GUO H,et al. Combined detection of serum Dickkopf-1 and its autoantibodies to diagnose esophageal squamous cell carcinoma[J]. Cancer Med,2016,5(7):1388-1396.[6] RICE T W,BLACKSTONE E H,RUSCH V W. 7th edition of the AJCC Cancer Staging Manual:esophagus and esophagogastric junction[J]. Ann Surg Oncol,2010,17:1721-1724.[7] STEIN H J,FEITH M,SIEWERT J R. Cancer of the esophagogastric junction[J]. Surg Oncol,2000,9(1):35-41.[8] 陈万青,张思维,陈志蜂. 中国食管癌胃癌高发区贲门癌流行趋势分析[J].中国肿瘤,2008,17(12):998-1000.[9] 彭裕辉,许镒洧,谢剑君. 血清DKK1在肿瘤临床应用中的价值[J].癌变·畸变·突变,2014,26(1) :79-81.[10] YAMABUKI T,TAKANO A,HAYAMA S,et al. Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas[J]. Cancer Res,2007,67(6):2517-2525.[11] HAN S X,ZHOU X,SUI X,et al. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer[J]. Oncotarget,2015,6(23):19907-19917.[12] HERREROS-VILLANUEVA M,BUJANDA L. Non-invasive biomarkers in pancreatic cancer diagnosis:what we need versus what we have[J]. Ann Transl Med,2016,4(7):134.[13] XU Y W,PENG Y H,CHEN B,et al. Autoantibodies as potential biomarkers for the early detection of esophageal squamous cell carcinoma[J]. Am J Gastroenterol,2014,109(1):36-45.[14] PENG Y H,XU Y W,HUANG L S,et al. Autoantibody signatures combined with Epstein-Barr virus capsid antigen-IgA as a biomarker panel for the detection of nasopharyngeal carcinoma[J]. Cancer Prev Res (Phila),2015,8(8):729-736. |